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a b s t r a c t
Condylomata acuminata is caused by human papillomavirus (HPV). PCR with consensus primers will
typically detect HPV in 496% of condylomata. Metagenomic sequencing has found that some “HPV-
negative” condylomata do indeed contain HPV. We wished to perform a renewed evaluation of the
“HPV-negative” condylomata using deeper metagenomics sequencing.
Sequencing of whole genome ampliﬁed DNA from 40 apparently “HPV-negative” condylomata
detected HPV in 37/40 specimens. We found 75 different HPV types, out of which 43 represented novel
putative HPV types. Three types were cloned and established as HPV types 200, 201 and 202. Molluscum
contagiosum virus was detected in 24 of the 40 samples.
In summary, deep sequencing enables detection of HPV in almost all condylomata. “HPV-negative”
condylomata might largely be explained by clinical misdiagnosis or the presence of viral variants,
distantly related HPV types and/or low viral loads.
& 2015 Elsevier Inc. All rights reserved.
Introduction
Human papillomaviruses (HPVs) are a large group of dsDNA-
viruses that infect keratinocytes of the skin and mucosa. About
200 different human papillomavirus (HPVs) types have been
completely cloned, sequenced and given an ofﬁcial number by
the International HPV Reference Center (www.hpvcenter.se,
accessed on 2015-05-28), which moved to Karolinska Institutet
from Heidelberg in 2013 (Bzhalava et al., 2015). In addition to the
established types, a large number of subgenomic HPV sequences
representing putatively novel HPV types have been discovered
using the broad general primer PCR system FAP (FA-isolates)
(Forslund, 2007), CUT PCR (GC-isolates) (Chouhy et al., 2010)
and/or using deep sequencing (SE-isolates) (Ekstrom et al., 2011).
Condylomata acuminata, anogenital warts, is a very common
sexually transmitted disease caused by HPV infection, most
commonly by HPV6 of the Alphapapillomavirus genus (Bernard
et al., 2010; Gissmann et al., 1982). A small proportion of
condylomata are reported to be “HPV-negative” and, besides
true negativity, 3 possible explanations have been suggested
(Walboomers and Meijer, 1997): (i) specimen inadequacy, (ii)
detection method insensitivity, and (iii) the existence of novel
HPV types that are not detectable by the method.
We have previously pointed out that extended analysis of HPV-
associated clinical lesions, such as cervical cancer or condyloma,
that are seemingly “HPV-negative” is a promising strategy to
discover new HPVs (Ekstrom et al., 2010). In southern Sweden, a
systematic condyloma reporting system has performed HPV gen-
otyping of the largest series of condylomata reported to date in the
literature (Sturegard et al., 2013). Overall, 96.3% of condylomata
were found to be HPV-positive, but a few were seemingly HPV-
negative in analyses even with broad HPV-primer PCR systems
(Soderlund-Strand et al., 2009).
Metagenomic sequencing can be used for an increased sensi-
tivity in HPV detection (Arroyo et al., 2013; Ekstrom et al., 2011) as
well as to obtain a comprehensive and more unbiased identiﬁca-
tion of the DNA present in samples, as no prior PCR or any prior
knowledge of the sequence is required (Bzhalava et al., 2014).
The aim of this study was to apply modern deep sequencing
technology, targeting individual “HPV-negative” condylomata, in
order to obtain a sensitive virus detection, also of putatively
novel HPVs.
Results
The DNA from the 40 condylomata specimens together with
2 negative controls (lab-grade water) were ampliﬁed using WGA,
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labeled with index tags and sequenced using Illumina deep sequen-
cing. Sequencing results from Illumina MiSeq were used to evaluate
DNA library quality, before sequencing them on Illumina NextSeq500.
MiSeq sequencing provided about 365Mb sequencing depth per
sample with a read length of 300 bp paired-end, whereas NextSeq
sequencing provided about 3.33 Gb sequencing depth per sample with
a read length of 150 bp paired-end.
Sequencing data from NextSeq consisted of 753 923 432 reads
whereof 363 182 were viral reads (0.05% of total sequences). The
majority of the viral reads, 329 636 reads, were related to HPV
sequences (91%). HPV sequences (with a cutoff of at least 5 reads
per HPV type) were found in 37/40 specimens (92.5%), representing a
total of 75 different HPV types or putative types within the genera
Alpha, Beta and Gamma. The HPV sequences belonged to 27 estab-
lished HPV types (including the 3 novel types that were found and
established in this study) (Table 1). In addition, 5 known putative HPV
types were detected in any of 7 samples and no less than 43
previously unknown HPV sequences, putatively representing novel
types were detected in any of 30 samples (Table 1). The previously
described known putative HPV types had partial sequences deposited
in GenBank, but had not been designated an ofﬁcial HPV type number
as they had not been cloned, submitted to the International HPV
Reference Center and completely sequenced. A Bayesian phylogenetic
tree of HPVs based on the L1 part of the 198 established HPV types as
well as the 3 novel putative HPV types (SE379, SE383, SE435) with
complete genomes and complete L1 regions are shown in Fig. 1, where
the different genera Alpha, Beta, Gamma, Mu and Nu are presented in
red, green, blue, orange and purple colors, respectively. The 3 novel
putative types cluster within the gamma genus.
Sample positivity for any HPV as well as for established types,
known and novel putative types as well as for molluscum contagio-
sum virus is shown in Table 1. HPV6 and HPV180 were the most
frequent genotypes, detected in 30 and 18 samples respectively. 13
established HPV types were detected in between 2 to 10 samples,
whereas 12 established HPV types were only present in single samples
(Table 1). Only 3 samples were negative for any known or putative
HPV type. Molluscum contagiosum virus was detected with a total of
27 538 reads, corresponding to 7.6% of all viral reads. Molluscum
positivity were detected in 24/40 samples (Table 1). 22 out of those 24
were also positive for HPV sequences. The rest of the virus related
reads (only corresponding to 1% of all viral reads) were related to
Baculoviridae, Herpesviridae, Microviridae, Mimiviridae, Parvoviridae,
Iridoviridae and unclassiﬁed viruses (Table 1). The number of these
non-HPV, non-molluscum virus related reads were not correlated to
the number of HPV, molluscum, as well as human, bacterial, unknown
or total number of non-virus related reads in the samples. No viruses
were detected in the 2 negative water controls.
All HPV-positive samples had more than 10 HPV reads. In fact,
28/40 samples had more than 100 HPV reads and of those,
7 samples had more than 10,000 HPV reads (Table 2). Based
only on established HPV types, 31/40 samples were positive
for multiple HPV types, being positive for up to 8 different
established types.
DNA sequences of novel putative HPV types
Overall, 46 novel HPV DNA sequences belonging to Beta and
Gamma genera were detected from the deep sequencing of the 40
condyloma specimens in this study. Six of the novel putative HPV
types represented complete HPV genomes (GenBank accession
number KP692114 to KP692119). Three of these were cloned
(isolates “SE370”, “SE371” and “SE372”). Clones and sequences
were sent to the International HPV Reference Center where they
were re-sequenced and established as new HPV types with the
designation HPV200, HPV201 and HPV202 (for “SE370”, “SE371”
and “SE372”, respectively) and reported in Table 1 as established
HPV types. They belonged to the genus Gamma-papillomavirus,
but with only 79%, 68% and 82% similarity to the most closely
related type (Table 3). HPV200 did not have any ORF correspond-
ing to the E4 gene. The sequences from the remaining 43 novel
putative types are deposited in GenBank, accession numbers
KP692120 to KP692178. Raw unassembled HPV related reads were
deposited in the SRA database with BioProject ID: 278583.
Comparison with previous 454 sequencing of the same specimens
A previous study sequenced these 40 apparently HPV-negative
condyloma specimen in pools of 4 samples with 454 pyrosequencing
on a GS Junior instrument (Roche) (12). HPV sequences were detected
in 5/10 pools from a total of 35 different HPV types: 13 now
established HPV types (HPV 5, 6, 50, 57, 58, 66, 105, 124, 130, 150,
165 (former isolate KC7), 175 (former isolate SE87) and 180 (former
isolate FA69)), 1 known putative HPV sequence (SE8) as well as 21
novel putative HPV sequences all belonging to the Gamma genus.
Read lengths of singletons and contigs ranged from 89 bp to 7356 bp
and samples were considered positive as long as 1 read was detected.
Among the 13 established HPV types detected, only 5 (HPV6, 50, 165,
175 and 180) generated contigs 4700 bp.
The deeper sequencing performed in this study conﬁrmed positiv-
ity (with a cutoff at 45 reads per sample) for 11 of the 13 established
Table 1
The number of samples that were positive (at least 5 reads for a particular type) for
the different HPV types and for each virus group.
Disease Condyloma
Number of samples 40
Virus group Number of positive samples
HPV 37a
Established HPV types 35a
HPV6 30
HPV180 18
HPV153 10
HPV57 9
HPV202 (SE372) 7
HPV165 3
HPV200 (SE370¼SE92, SE94, SE95, SE100) 3
HPV201 (SE371¼SE107, SE106, SE116, SE183) 3
HPV28 2
HPV37 2
HPV66 2
HPV124 2
HPV130 2
HPV148 2
HPV150 2
HPV31 1
HPV49 1
HPV50 1
HPV58 1
HPV101 1
HPV105 1
HPV118 1
HPV120 1
HPV137 1
HPV138 1
HPV140 1
HPV147 1
Known putative HPV types 7a
Novel putative HPV types 30a
Molluscum contagiosum 24
Mimiviridae 20
Baculoviridae 13
Herpesviridae 11
Iridoviridae 5
Microviridae 2
Parvoviridae 2
unclassiﬁed 5
a The number of samples that were positive for at least 1 of the HPV types
within the group.
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HPV types detected in the previous study. The established types HPV5
and HPV175 as well as the known putative sequence SE8 were not
detected in this study. 13 of the 21 novel putative HPVs (SE92-100,
SE106, SE107, SE109 and SE116) were also detected in this study. As
suggested in the previous study (12), the 9 phylogenetically related but
non-overlapping fragments SE92-100 were found to belong to the
same novel HPV type (HPV200) that was cloned and sequenced in the
present study. Furthermore, the 3 non-overlapping sequence frag-
ments SE106, SE107 and SE116 were all found to belong to HPV201,
also cloned and sequenced in the present study.
Discussion
Deep sequencing using Illumina has demonstrated an increased
sensitivity for HPV detection, with all but 3 “HPV-negative”
condylomata (37/40) now being positive for at least one HPV type.
Overall, we found 75 different HPV types in the 40 “HPV-negative”
condyloma samples (27 established HPV types, 5 known putative
HPV types and 43 novel putative types). Several samples were
found to contain established HPV types known to cause condylo-
mata, in particular HPV6, although the PCR methods used should
have detected these viruses (Aubin et al., 2008; de Villiers et al.,
2004; Sturegard et al., 2013). Possible explanations include the
presence of viral variants with genomic substitutions in the
sequences targeted by PCR primers or probes. Deep sequencing
overcomes this problem by detecting HPV types without any prior
sequence information, independent of PCR.
In this study, we compared data from modern deep sequencing
using Illuminawith previous data using 454 sequencing. As expected,
more HPV types were detected with the deeper sequencing. It also
generated longer contigs of HPV sequences. A total of 46 putative
novel types were detected, belonging to either Beta or Gamma
genera. Beta- and gamma-HPVs are frequently detected on healthy
skin (Antonsson et al., 2003; Ekstrom et al., 2013; Forslund et al.,
2004; Foulongne et al., 2012) and therefore, presence of these types
might be due to biological contamination from adjacent healthy
genital skin. Interestingly, the Merkel cell polyomavirus which is
known to be commonly present in healthy skin was not detected.
Clinical distinction between condyloma and mollusca is not an
easy task. Presence of molluscum contagiosum virus is also known
to exist concomitantly with presence of HPV(Castronovo et al.,
2012). In our study, molluscum contagiosumwas detected in 24/40
condyloma samples and 22 out of those 24 also contained HPV
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Fig. 1. Bayesian phylogenetic tree based on the L1 part of the complete 198 established HPV types and 3 putative novel HPV types (SE-types.). Alpha, Beta, Gamma, Mu and
Nu papillomaviruses are presented in red, green, blue, orange and purple colors, respectively.
Table 2
The number of samples within each range of
HPV reads.
Number of HPV reads Number of samples
0 1
1r10 0
10r100 11
100r1000 12
1000r10,000 9
10,000r100,000 7
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sequences. This leaves only a single condyloma specimen where
we did not ﬁnd neither HPV, nor molluscum contagiousum virus.
The detection of multiple viruses in the diseased tissue does not
imply causality, as this study did not analyze matched controls.
In summary, deep sequencing of apparently “HPV-negative”
condylomata specimen greatly reduces the number of “HPV-
negative” specimens. Sequencing of apparently HPV-negative
specimens from diseases known to be HPV-associated continues
to identify a large number of previously unknown HPV sequences.
Importance
Conventional methods fail to detect papillomaviruses (HPV) in a
small proportion of genital warts (condylomata), a disease established
as caused by HPV. Modern deep sequencing is not based on prior
knowledge of sequence information, can increase the analytic sensi-
tivity of HPV detection as well as detect viral variants and distantly
related viruses. We sequenced 40 apparently HPV-negative genital
warts and observed that 37/40 samples did contain HPV, including 43
previously unknown apparently new HPV types. This suggests that
seemingly HPV-negative condylomata might be explained by e.g.,
clinical misdiagnosis or presence of viral variants, low viral loads or
presence of previously unknown HPV types.
Material and methods
Patients
40 swab samples of apparently HPV-negative condylomata
from 21 women and 19 men (Johansson et al., 2013) were analyzed
with Illumina sequencing technology. Swab samples were col-
lected with a pre-wetted (0.9% NaCl) cotton-tipped swab rolled
over the condyloma and stored in 1 mL saline. Samples were then
centrifuged (5 min, 3500G) and 500 μL of the supernatant were
left for pellet re-suspension. 200 μL were used for DNA extraction
with MagNA Pure LC using the Total Nucleic Acid Kit (Roche) and
DNA was eluted in 100 μL elution buffer.
Informed consent was obtained from all participants, the study
adhered to the declaration of Helsinki and was approved by the
Ethical Review Committee of Lund University (Sweden).
Sample preparation
Sample adequacy was assayed using beta-globin PCR, visua-
lized by gel electrophoresis in 11 cases and by real-time PCR in 29
cases (Sturegard et al., 2013). In order to amplify the DNA in the
sample, extracted DNA from 40 individual samples and 2 negative
controls (water) were subjected to whole genome ampliﬁcation
(WGA) using GenomiPhi High Yield (GE Health Care, United
Kingdom). WGA was performed according to manufacturer´s
instructions with some modiﬁcations. 5 ml of sample were diluted
with 20 ml sample buffer. The mix was incubated at 95 1C for 3 min
and then cooled on ice. 22.5 μL of reaction buffer was mixed with
2.5 μL of enzyme mix and added to the diluted sample. Samples
were incubated at 30 1C for 7 h and inactivated at 65 1C for 10 min.
Products were dissolved by diluting samples 1:2 in PCR-Grade
water. All ampliﬁcation products were quantiﬁed with
QuantiFluor-ST (Promega, US) and a quality analysis (Bioanalyzer,
Agilent) was performed to check the DNA fragments size distribu-
tion prior library preparation.
Deep sequencing
For each sample, 50 ng of WGA DNA were tagmented and
ampliﬁed using the Nextera DNA Sample Preparation kit according
to the user guide revision B (Illumina). Two sample tags, a unique
combination for each sample, were used in the short PCR ampli-
ﬁcation step to facilitate multiplex sequencing. All individual
libraries were validated, normalized to 4 nM and pooled.
Prior to sequencing, the 42 individual indexed libraries (40
specimens and 2 negative controls) were denatured and diluted,
resulting in a 15 pM DNA solution. PhiX control was spiked at 1%
and the pool was sequenced by paired-end 301þ301 cycles using
MiSeq version 3 reagent kit (Illumina, US). The sequencing
preparations were made according to the user guides Preparing
Libraries for Sequencing on the MiSeq revision C, Reagent Pre-
paration Guide revision A and MiSeq System User Guide revision
K. For an even deeper sequencing, the 42 individual indexed
libraries were sequenced using the NextSeq500 instrument. The
pool was denatured and diluted, resulting in a 2.6 pM DNA
solution. PhiX control was spiked at 1% and the pool was
sequenced by paired-end 151þ151 cycles using NextSeq 500 High
Output reagent kit (Illumina, US). The sequencing preparations
were made according to the user guides Denaturing and Diluting
Table 3
The 3 novel established HPV types (HPV200, HPV201 and HPV202) genome organizations and their similarities of the open reading frames (ORFs) to the closest related
HPV types.
HPV200 (SE370) Total E6 E7 E1 E2 E4 L2 L1
Number of nucleotides (nt)a 7137 420 282 1797 1206 x 1509 1545
Position of ORF in genome – 1–420 417–698 685–2481 2408–3613 x 3613–5121 5132–6676
Number of amino acids (aa) – 140 94 599 402 x 503 515
HPV200 vs HPV48 Gamma-2% identity on nt level (aa level) – 78 (72) 81 (84) 79 (80) 82 (79) x 77 (73) 79 (86)
HPV201 (SE371) Total E6 E7 E1 E2 E4 L2 L1
Number of nucleotides (nt)a 7291 423 297 1827 1257 549 1554 1527
Position of ORF in genome – 1–423 420–716 700–2526 2468–3724 2934–3482 3726–5279 5289–6815
Number of amino acids (aa) – 141 99 609 419 183 518 509
HPV201 vs HPV163 Gamma-20% identity on nt level (aa level) – 62 (47) 64 (50) 66 (51) 67 (54) – 65 (55) 68 (68)
HPV202 (SE372) Total E6 E7 E1 E2 E4 L2 L1
Number of nucleotides (nt)a 7344 432 300 1818 1179 369 1497 1587
Position of ORF in genome – 1–432 434–733 717–2534 2470–3648 3041–3409 3650–5146 5155–6741
Number of amino acids (aa) – 144 100 606 393 123 499 529
HPV202 vs HPV140 Gamma-11% identity on nt level (aa level) – 87 (89) 86 (90) 87 (90) 88 (86) 90 (86) 77 (79) 82 (92)
a Including STOP codon.
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Libraries for the NextSeq 500 revision A and NextSeq 500 kit
Reference Guide revision F.
Bioinformatic analysis
Sequences obtained fromMiSeq and NextSeq platforms and the
indexing tags, included in the Illumina primers, were used to
assign the sequence reads to the originating samples. The bioin-
formatic analysis started with quality checking where sequences
were trimmed according to their Phred quality scores (Ewing and
Green, 1998). Quality checked reads were then screened against
the human reference genome hg19, as well as bacterial, phage and
vector sequences downloaded from GenBank using BWA-MEM (Li
and Durbin, 2010) and reads with 495% identity over 75% of their
length to human DNA were removed from further analysis. The
rest of the sequences were normalized (http://ged.msu.edu/
papers/2012-diginorm) to discard redundant data and reduce
sampling variation and sequencing errors. The normalized dataset
was then processed for assembly using the Trinity (Haas et al.,
2013), SOAPdenovo-Trans (http://soap.genomics.org.cn/) and
IDBA-UD (Peng et al., 2012) assemblers into contiguous sequences
(contigs). Reads before assembly were re-mapped to assembled
contigs. The use of several assembly algorithms and re-mapping of
all singleton reads to assembled contigs was used to validate
assembly results (Bzhalava et al., 2013; Meiring et al., 2012).
Assembled contigs were then subjected to taxonomic classiﬁcation
using GenBank and paracel blast (www.paracel.com) to classify
them as i) previously known sequences, ii) related to previously
known sequences, or iii) unrelated to any previously known
sequences.
All papillomavirus-related contigs and singletons were checked
as described to identify possible artifactual “chimeric” sequences
(contigs containing sequences originating from different viruses)
(Bzhalava et al., 2013). Shortly, the sequence that aligned to its
most closely related sequence in GenBank was divided into three
equal segments. If at least one of the segments differed in
similarity to the corresponding overlapping parts with more than
5% (for example if segment 1 was 88% similar and segment 2 was
94% similar) the sequence was considered as a “possible chimera”
and not analyzed further.
Papillomavirus-related contigs having Z90% identity with
each other were clustered. The total number of sequencing reads
from each cluster was calculated and the longest contig was
selected as a representative to remove redundancy. Clustering
analysis was conducted separately for contigs longer and shorter
than 700 bp length. Based on the percent similarity to the closest
related type in GenBank, HPV related contigs were classiﬁed as
known established, known putative and novel putative HPV types.
For each of the HPV types, the total number of reads was
calculated and specimens were considered positive if at least
5 reads from the same HPV type were detected in the same
specimen.
All analyses were performed using in-house R (www.R-project.
org/), python (www.python.org) and bash (http://www.gnu.org/
software/bash/) scripts that ran on a high performance (40 core,
2 TB RAM) Linux server.
Characterization of HPV200, 201 and 202
The complete genome sequence was obtained for 6 previously
unknown HPV sequences, putatively representing new HPV types.
3 of the 6 complete putative novel HPV genomes, “SE370”, “SE371”
and “SE372” isolates, were ampliﬁed and cloned from their
respective specimens in 2 overlapping fragments each. The frag-
ments were ampliﬁed using PrimeSTAR GXL DNA Polymerase from
TAKARA, according to manufacturer's instructions. The ﬁrst
fragment containing the L1 regionwas ampliﬁed using the primers
SE370AF 50-TGAGGAAGGAGACACTGTTACT-30 and SE370AR 50-ACT
TCCCGCCTCTGTTTGA-30; SE371AF 50-TCCAGAGTCAGGCTTTGTGT-30
and SE371AR 50-AGCATCTGACACCTGTTCCA-30; SE372AF 50-ACAT-
GAGCCCTATACCACGG-30 and SE372AR 50-TTTGAGAGTTGAACAG
CGCC-30 for “SE370”, “SE371” and “SE372” isolates, respectively.
The second fragment was ampliﬁed using the primers SE370BF 50-
GACAGCAGAGGAGGAGTTGT-30 and SE370BR 50-CTACAGGAGCAC-
TAGGAGGC-30; SE371BF 50-GTTTTCGGTTGCAGGCATTG-30 and SE3
71BR 50-CTAAAACCGGCACAGTAGGC-30; SE372BF 50-TCCAGAGT-
CAGGCTTTGTGT-30 and SE372BR 50-AAACGCCAAACCAACCTCTC-30
for “SE370”, “SE371” and “SE372” isolates respectively. The PCR-
program for all fragments consisted on 30 cycles at 98 1C for 10 s,
55 1C for 15 s and 68 1C for 8 min. The PCR products were gel-
puriﬁed and cloned using the Zero Blunts TOPOs PCR Cloning kit
(Invitrogen) and the pCRTM-Blunt II-TOPOs vector, according to
manufacturer's instructions and incubated overnight.
The complete cloned genomes for the 3 novel HPV types were
also sequenced by Sanger sequencing to conﬁrm the sequence
obtained with the MiSeq instrument from each index sample,
using designed primers for conventional primer walking. Clones
were sent to the International HPV Reference Center (Karolinska
Institutet, Sweden) that conﬁrmed the DNA sequence and assigned
the submitted clones the novel HPV type number 200, 201 and
202 for “SE370”, “SE371” and “SE372”, respectively.
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